CA
NZ
UK
AU
IND
US
…
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for 3-D Matrix Ltd (DMTRF) are limited; the issuer trades on the OTC Pink and available filings do not clearly define its core operations. Long-term growth depends on successful commercialization, securing material contracts, and improved corporate disclosure, which could support a re-rating if executed. Investors may find potential upside if management delivers verifiable results, but transparency and liquidity constrain near-term prospects.
Primary risks are very low liquidity, limited verifiable financial information, potential governance and reporting shortfalls, execution uncertainty, and regulatory or market-admission challenges associated with microcap OTC-listed issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
| Income before tax | -2479.12M | -24.63M | -2443.87M | -1893.55M | -2011.41M |
| Net income | -2501.24M | -255.50M | -2445.98M | -1894.76M | -2012.62M |
| Selling general administrative | 5082.56M | 4647.85M | 3995.08M | 2713.16M | 2168.16M |
| Selling and marketing expenses | - | 503.00M | - | - | - |
| Gross profit | 4424.59M | 3086.40M | 1288.28M | 661.01M | 304.91M |
| Ebit | - | -4234.04M | -3158.34M | -2736.65M | -2648.64M |
| Ebitda | -2404.71M | -2117.04M | -2334.68M | -1802.29M | -1895.66M |
| Depreciation and amortization | - | 2117.00M | 823.66M | 934.36M | 752.97M |
| Operating income | -1156.17M | -2117.04M | -3158.34M | -2736.65M | -2648.64M |
| Other operating expenses | 8090.31M | 6705.86M | 5472.43M | 4242.88M | 3673.01M |
| Interest expense | 74.41M | 83.76M | 60.56M | 4.78M | 4.68M |
| Tax provision | 22.12M | 230.87M | 2.10M | 1.21M | 1.21M |
| Interest income | 0.60M | 0.05M | 0.10M | 1.24M | 0.09M |
| Net interest income | -85.91M | -92.83M | -68.42M | -12.53M | -17.02M |
| Income tax expense | 22.12M | 230.87M | 2.10M | 1.21M | 1.21M |
| Total revenue | 6934.14M | 4588.82M | 2314.08M | 1506.23M | 1024.38M |
| Total operating expenses | 5580.76M | 5203.44M | 4446.62M | 3397.66M | 2953.54M |
| Cost of revenue | 2509.55M | 1502.42M | 1025.81M | 845.22M | 719.47M |
| Total other income expense net | -1322.95M | 2092.41M | 714.47M | 843.10M | 637.23M |
| Net income from continuing ops | -2501.24M | -255.50M | -2445.98M | -1894.76M | -2012.61M |
| Net income applicable to common shares | - | - | -2445.00M | -1894.00M | -2012.00M |
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
| Total assets | 6513.12M | 5886.28M | 5825.52M | 5610.72M | 3508.29M |
| Other current assets | 421.91M | 396.59M | 345.32M | 280.68M | 253.78M |
| Total liab | 4296.93M | 5532.98M | 5300.75M | 4153.00M | 1848.46M |
| Total stockholder equity | 2216.19M | 353.31M | 524.77M | 1457.72M | 1659.83M |
| Other current liab | 588.59M | 902.87M | 802.90M | 467.10M | 366.05M |
| Common stock | 15489.93M | 13818.00M | 12675.39M | 11550.84M | 10312.76M |
| Capital stock | 15489.93M | 13818.46M | 12675.39M | 11550.84M | 10312.76M |
| Retained earnings | -26265.49M | -23764.24M | -23508.74M | -21062.76M | -19168.00M |
| Other liab | - | - | 126.00M | 20.00M | 25.00M |
| Other assets | 0.00M | - | 0.00M | 0.00M | 0.00M |
| Cash | 1580.27M | 1363.54M | 1170.90M | 2848.64M | 1137.80M |
| Total current liabilities | 1578.89M | 1536.85M | 1302.90M | 867.10M | 773.65M |
| Current deferred revenue | - | -1.00M | - | - | - |
| Net debt | 1360.41M | 2810.28M | 3202.92M | 816.45M | 319.80M |
| Short term debt | 300.00M | 300.00M | 500.00M | 400.00M | 407.60M |
| Short long term debt | 300.00M | 300.00M | 500.00M | 400.00M | 407.60M |
| Short long term debt total | 2940.68M | 4173.82M | 4373.82M | 3665.09M | 1457.60M |
| Other stockholder equity | 12991.76M | 10299.09M | 11358.12M | 10969.64M | 10515.07M |
| Total current assets | 6418.79M | 5791.75M | 5667.42M | 5577.52M | 3475.99M |
| Net tangible assets | - | - | 524.00M | 1458.00M | 1660.00M |
| Net receivables | 1925.43M | 1170.72M | 1159.25M | 647.03M | 506.60M |
| Long term debt | 2640.68M | 3873.82M | 3873.82M | 3265.09M | 1050.00M |
| Inventory | 2491.18M | 2860.90M | 2991.95M | 1801.17M | 1577.80M |
| Accounts payable | 602.86M | 1.00M | - | - | - |
| Accumulated other comprehensive income | - | -3509.00M | - | - | - |
| Non currrent assets other | 94.33M | 86.13M | 158.10M | 8.24M | 8.68M |
| Non current assets total | 94.33M | 94.53M | 158.10M | 33.20M | 32.30M |
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
| Investments | -33.30M | -29.76M | -81.50M | -79.86M | -160.32M |
| Change to liabilities | - | - | 0.00M | 41.00M | -468.00M |
| Total cashflows from investing activities | -33.30M | -29.76M | - | -79.00M | -160.00M |
| Net borrowings | -599.32M | -200.00M | - | 2557.00M | 7.00M |
| Total cash from financing activities | 2013.74M | 2062.56M | 2955.54M | 4663.64M | 3462.80M |
| Change to operating activities | - | - | - | -691.00M | -857.00M |
| Net income | -2479.12M | -24.63M | -2443.87M | -1893.55M | -2011.41M |
| Change in cash | 216.73M | 192.63M | -1677.74M | 1710.84M | 79.75M |
| Begin period cash flow | 1363.54M | 1170.90M | 2848.64M | 1137.80M | 1058.05M |
| End period cash flow | 1580.27M | 1363.54M | 1170.90M | 2848.64M | 1137.80M |
| Total cash from operating activities | -1714.10M | -1899.88M | -4585.08M | -2903.27M | -3249.74M |
| Issuance of capital stock | 2616.47M | 2246.69M | 304.10M | 2094.88M | 3444.41M |
| Other cashflows from investing activities | -21.69M | -28.76M | - | -66.00M | -135.00M |
| Change to inventory | 294.43M | 419.87M | -1054.32M | -195.01M | 1.95M |
| Change to account receivables | -815.26M | -482.75M | - | -255.00M | -32.00M |
| Other cashflows from financing activities | -3.42M | 15.87M | 2651.44M | 2568.76M | 18.40M |
| Change to netincome | - | - | - | 90.00M | 118.00M |
| Capital expenditures | 12.31M | 4.33M | 18.70M | 13.12M | 25.78M |
| Change in working capital | -157.39M | 348.84M | -1225.15M | -261.10M | -698.39M |
| Stock based compensation | 23.42M | 36.77M | 34.25M | 31.46M | 50.51M |
| Other non cash items | 898.99M | -2260.85M | -950.31M | -780.08M | -590.45M |
| Free cash flow | -1726.41M | -1904.21M | -4603.79M | -2916.39M | -3275.51M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DMTRF 3-D Matrix Ltd |
- -% |
2.42 | - | - | 0.06 | 14.58 | 8.15 | 200.01 |
| ABT Abbott Laboratories |
-1.78 1.70% |
103.10 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-0.84 0.89% |
93.95 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-4.71 1.54% |
301.42 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
- -% |
47.55 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan
| Name | Title | Year Born |
|---|---|---|
| Mr. Jun Okada | Pres & Representative Director | 1974 |
| Mr. Satoru Kobayashi | Head of Bus. Devel. & Director | NA |
| Mr. Takao Miki | Head of EMEA Bus. & Director | NA |
| Andy Kim | Exec. Officer | NA |
| Marie Buffier | Exec. Officer | NA |
| Mr. Keiji Nagano MBA | Executive Chairman of the Board | 1954 |
| Dr. Shuguang Zhang Ph.D. | Founder | NA |
| Mr. Satoru Kobayashi | Executive Officer, Head of Business Development & Director | 1980 |
| Mr. Hisato Yuto | Executive Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+1.59%
Communication Services
+0.05%
Consumer Cyclical
+0.14%
Consumer Defensive
-0.43%
Energy
-0.03%
Financial Services
+0.19%
Financials
-0.35%
Healthcare
+1.05%
Industrials
+0.67%
Real Estate
-0.25%
Technology
+1.31%
Utilities
+0.32%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...